Arcutis Biotherapeutics Inc
ARQT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.61B
Close$
$-28.99
205.3% downside
Current Fair Value
205.3% downsideOvervalued by 205.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.61 Billion |
|---|---|
| Enterprise Value | $3.69 Billion |
| Earnings per Share | $-0.13 |
| Beta | 1.63 |
| Outstanding Shares | 131,011,000 |
Return
| Return on Equity | 12.26% |
|---|---|
| Return on Assets | 5.70% |
| Return on Invested Capital | 11.45% |
Valuation & Multiples
| P/E Ratio | 109.8 |
|---|---|
| PEG | 584.91 |
| Price to Sales | 9.18 |
| Price to Book Ratio | 27.53 |
| Enterprise Value to Revenue | 7.25 |
| Enterprise Value to EBIT | 91.47 |
| Enterprise Value to Net Income | 123 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.47 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 4, 2026
EPS
$0.06
Est. $0.18Revenue
$143.92 M
Est. $142.59 MNext Earnings Call
Expected Date
February 24, 2027
EPS Estimate
$0.21
Consensus analyst estimateRevenue Estimate
$163.07 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 8.42% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 9.27%▼ 92.24% |
|---|---|
| Total Invested | $320.12M▼ 90.79% |
| Investors Holding | 112▼ 171.00% |